Home › Crohn's Disease › Illinois › Chicago

Pag-aaral pangklinika para sa Crohn's Disease sa Chicago, IL

9 pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Chicago (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

University of Chicago Medical Center ( Site 5066), Chicago

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

University of Chicago Medical Center /ID# 267400, Chicago

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Rush University Medical Center, Chicago

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Rush University Medical Center-Site Number: 8400015, Chicago

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Nagre-recruitPhase 2

Rush University Medical Center, Chicago

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483099

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Nagre-recruitPhase 2

Rush University Medical Center, Chicago

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

University of Chicago Medicine, Chicago

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Nagre-recruit

University of Chicago Medicine, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05230173

Treatment of Moderate to Severe Refractory Crohn's Disease

Nagre-recruitPhase 1/2

Northwestern, Chicago
University of Chicago, Chicago

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT06721962

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.